 BERWYN, Pa. , Oct. 20, 2022 PRNewswire -- NYSE: ANVS Annovis Bio Annovis or the Company, a clinical-stage drug platform company addressing neurodegenerative diseases, announced today that it will present at the ThinkEquity 2022 Investor Conference on Wednesday, October 26, 2022, in New York City. 